Planta Med 2015; 81(12/13): 1141-1145
DOI: 10.1055/s-0035-1545979
Natural Product Chemistry
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron reticulatum [*]

Mamona Nazir
1   Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
,
Henrik Harms
1   Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
,
Irene Loef
1   Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
,
Stefan Kehraus
1   Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
,
Fayrouz El Maddah
1   Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
,
Idris Arslan
2   Pamukkale University, Biomedical Engineering, Denizli, Turkey
,
Viktor Rempel
3   Pharma Center Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
,
Christa E. Müller
3   Pharma Center Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, Bonn, Germany
,
Gabriele M. König
1   Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
› Author Affiliations
Further Information

Publication History

received 12 March 2015
revised 30 March 2015

accepted 31 March 2015

Publication Date:
08 May 2015 (online)

Abstract

The marine sponge-derived fungus Auxarthron reticulatum produces the cannabinoid receptor antagonist amauromine (1). Recultivation of the fungus to obtain further amounts for more detailed pharmacological evaluation of 1 additionally yielded the novel triterpene glycoside auxarthonoside (2), bearing, in nature, a rather rare sugar moiety, i.e., N-acetyl-6-methoxy-glucosamine. Amauromine (1), which inhibited cannabinoid CB1 receptors (Ki 0.178 µM) also showed antagonistic activity at the cannabinoid-like orphan receptor GPR18 (IC50 3.74 µM). The diketopiperazine 1 may thus serve as a lead structure for the development of more potent and selective GPR18 antagonists, which are required to study the orphan receptorʼs potential as a new drug target. Despite the execution of many biological assays, to date, no bioactivity could be found for auxarthonoside (2).

* Dedicated to Professor Dr. Dr. h. c. mult. Adolf Nahrstedt on the occasion of his 75th birthday.


Supporting Information

 
  • References

  • 1 Elsebai MF, Rempel V, Schnakenburg G, Kehraus S, Müller CE, König GM. Identification of a potent and selective cannabinoid CB1 receptor antagonist from Auxarthron reticulatum . ACS Med Chem Lett 2011; 2: 866-869
  • 2 Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 2010; 62: 588-631
  • 3 Balenga NA, Henstridge CM, Kargl J, Waldhoer M. Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55. Adv Pharmacol 2011; 62: 251-277
  • 4 Liu B, Song S, Jones PM, Persaud SJ. GPR55: from orphan to metabolic regulator?. Pharmacol Ther 2015; 145: 35-42
  • 5 McHugh D. GPR18 in microglia: implications for the CNS and endocannabinoid system signaling. Br J Pharmacol 2012; 167: 1575-1582
  • 6 Altona C, Haasnoot CAG. Prediction of anti and gauche vicinal proton-proton coupling constants in carbohydrates: a simple additivity rule for pyranose rings. Org Magn Reson 1980; 13: 417-429
  • 7 Tanaka Y, Sato H, Kageyu A, Tomita T. Separation of geranylgeraniol isomers by highperformance liquid chromatography and identification by 13C nuclear magnetic resonance spectroscopy. J Chromatogr 1985; 347: 275-283
  • 8 Wakaka D, Hosoe T, Itabashi T, Fukushima K, Kawai K. Two new glycosides, malfilamentosides A and B, from Malbranchea filamentosa . Mycotoxins 2008; 58: 1-6
  • 9 Harms H, Rempel V, Kehraus S, Kaiser M, Hufendiek P, Müller CE, König GM. Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors. J Nat Prod 2014; 77: 673-677
  • 10 Rempel V, Atzler K, Behrenswerth A, Karcz T, Schöder C, Hinz S, Kaleta M, Thimm D, Kiec-Kononowicz K, Müller CE. Bicyclic imidazole-4-one derivatives: a new class of antagonists for the orphan G protein-coupled receptors GPR18 and GPR55. MedChemComm 2014; 5: 632-649
  • 11 Krumbein WE, Hoog GS, Urzí C. On the isolation of microcolonial fungi occurring on and in marble and other calcareous rocks. Sci Total Environ 1995; 167: 287-294
  • 12 Rempel V, Volz N, Gläser F, Nieger M, Bräse S, Müller CE. Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold. J Med Chem 2013; 56: 4798-4810